Rockwell Medical (RMTI) Invested Capital (2013 - 2026)

Rockwell Medical (RMTI) has reported Invested Capital for 11 consecutive years, with $44.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 4.43% year-over-year to $44.1 million; the trailing twelve-month figure through Jun 2026 stood at $44.1 million (up 4.43% YoY), and the FY2025 full-year result was $47.1 million, up 7.72% from the prior year.
• Invested Capital eased to $44.1 million in Q2 2026 per RMTI's latest filing, from $44.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $48.0 million in Q3 2025 and bottomed at $13.6 million in Q1 2022.
• Historically, Invested Capital has averaged $34.7 million across 5 years, with a median of $35.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Invested Capital slumped 71.3% in 2022, then soared 85.0% in 2024.
• Over 5 years, Invested Capital stood at $23.3 million in 2022, then surged by 38.79% to $32.3 million in 2023, then jumped by 35.17% to $43.7 million in 2024, then advanced by 7.72% to $47.1 million in 2025, then dropped by 6.34% to $44.1 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $44.1 million, $44.8 million, and $47.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.